Approximately 10% of patients with aggressive PC carry germline pathogenic variants in genes with established roles in cancer predisposition (BRCA2, ATM, CHEK2, NBN, BRCA1, PALB2, BRIP1, BARD1). This evidence concerns the gene BRCA2 and cancer.